These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2138291

  • 1. Chronic zimeldine administration to cats: sustained increase of serotonergic effect as measured with sleep parameters.
    Sommerfelt L.
    Pharmacol Toxicol; 1990 Feb; 66(2):128-32. PubMed ID: 2138291
    [Abstract] [Full Text] [Related]

  • 2. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1991 Nov 26; 45(2):105-15. PubMed ID: 1838688
    [Abstract] [Full Text] [Related]

  • 3. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1987 Apr 26; 24(1):1-10. PubMed ID: 2953350
    [Abstract] [Full Text] [Related]

  • 4. Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats.
    Sommerfelt L, Hauge ER, Ursin R.
    J Neural Transm; 1987 Apr 26; 68(1-2):127-44. PubMed ID: 2949058
    [Abstract] [Full Text] [Related]

  • 5. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul 26; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 6. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L, Ursin R.
    Sleep; 1993 Jan 26; 16(1):15-22. PubMed ID: 8456229
    [Abstract] [Full Text] [Related]

  • 7. Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity.
    Ross RJ, Ball WA, Levitt DR, Gresch PJ, Morrison AR.
    Neuropharmacology; 1990 Oct 26; 29(10):965-8. PubMed ID: 2255389
    [Abstract] [Full Text] [Related]

  • 8. Does para-chlorophenylalanine produce disturbed waking, disturbed sleep or activation by ponto-geniculo-occipital waves in cats?
    Ursin R.
    Waking Sleeping; 1980 Oct 26; 4(3):211-21. PubMed ID: 6456599
    [Abstract] [Full Text] [Related]

  • 9. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
    Ursin R, Bjorvatn B.
    Sleep Res Online; 1998 Oct 26; 1(3):119-27. PubMed ID: 11382868
    [Abstract] [Full Text] [Related]

  • 10. Elicited pontogeniculooccipital waves and phasic suppression of diaphragm activity in sleep and wakefulness.
    Hunt WK, Sanford LD, Ross RJ, Morrison AR, Pack AI.
    J Appl Physiol (1985); 1998 Jun 26; 84(6):2106-14. PubMed ID: 9609806
    [Abstract] [Full Text] [Related]

  • 11. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R, Bjorvatn B, Sommerfelt L, Underland G.
    Behav Brain Res; 1989 Aug 01; 34(1-2):117-30. PubMed ID: 2527519
    [Abstract] [Full Text] [Related]

  • 12. Dependence of REM sleep PGO waves on cholinergic mechanisms.
    Henriksen SJ, Jacobs BL, Dement WC.
    Brain Res; 1972 Dec 24; 48():412-6. PubMed ID: 4345602
    [No Abstract] [Full Text] [Related]

  • 13. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 14. The role of serotonin in the regulation of a phasic event of rapid eye movement sleep: the ponto-geniculo-occipital wave.
    Henriksen S, Dement W, Barchas J.
    Adv Biochem Psychopharmacol; 1974 Nov 30; 11(0):169-79. PubMed ID: 4367643
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H, Burki HR.
    Neuropsychobiology; 1987 Nov 30; 17(4):206-12. PubMed ID: 2964564
    [Abstract] [Full Text] [Related]

  • 16. Serotonin neurons and sleep. I. Long term recordings of dorsal raphe discharge frequency and PGO waves.
    Lydic R, McCarley RW, Hobson JA.
    Arch Ital Biol; 1987 Oct 30; 125(4):317-43. PubMed ID: 3439827
    [Abstract] [Full Text] [Related]

  • 17. Dose-related suppression of REM sleep and PGO waves by the serotonin-1 agonist eltoprazine.
    Quattrochi JJ, Mamelak AN, Binder D, Williams J, Hobson JA.
    Neuropsychopharmacology; 1993 Jan 30; 8(1):7-13. PubMed ID: 8424848
    [Abstract] [Full Text] [Related]

  • 18. Microinjections into the pedunculopontine tegmentum: effects of the GABAA antagonist, bicuculline, on sleep, PGO waves and behavior.
    Sanford LD, Hunt WK, Ross RJ, Morrison AR, Pack AI.
    Arch Ital Biol; 1998 Jul 30; 136(3):205-14. PubMed ID: 9645310
    [Abstract] [Full Text] [Related]

  • 19. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE, Neckelmann D, Ursin R.
    Behav Brain Res; 1994 Dec 15; 65(2):195-203. PubMed ID: 7718152
    [Abstract] [Full Text] [Related]

  • 20. Phasic changes in heart rate and respiration correlated with PGO-spike activity during REM sleep.
    Baust W, Holzbach E, Zechlin O.
    Pflugers Arch; 1972 Dec 15; 331(2):113-23. PubMed ID: 4336783
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.